GlassScriptPhysician profile
Christopher V Hutchison
NPI 1134151384
$73,959.62
in general payments reported to CMS, 2019-2025
25 companies · $1,851 in 2025
The $1,851 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $9,921 · 2021: $11K · 2022: $1,897 · 2023: $1,722 · 2024: $6,709 · 2025: $1,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,997 · Travel and Lodging: $2,405 · Food and Beverage: $880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,997.40 |
| Travel and Lodging | $2,404.82 |
| Food and Beverage | $880.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $59,757.64 | 2019-2025 | |
| Intuitive Surgical, INC. | $6,464.21 | 2024 | |
| Organon LLC | $4,544.03 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $2,062.12 | 2019 | |
| Biogen, INC. | $149.35 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $136.43 | 2021-2025 | Slynd |
| Medtronic, INC. | $133.96 | 2022-2024 | Intellis Adaptivestim |
| Pfizer INC. | $127.96 | 2022-2025 | |
| Hologic Sales and Service, LLC | $114.99 | 2019-2024 | Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $95.71 | 2019-2023 | |
| Evofem Biosciences, INC. | $58.62 | 2021 | |
| Coopersurgical, INC. | $50.51 | 2022-2025 | Ally II Ups |
| Axonics, INC. | $47.91 | 2020-2024 | Bulkamid |
| Sumitomo Pharma America, INC. | $28.58 | 2025 | Myfembree |
| Myovant Sciences INC. | $25.95 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $23.70 | 2021 | |
| Ethicon US, LLC | $23.62 | 2025 | Vistaseal |
| Therapeuticsmd, INC. | $19.59 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $17.59 | 2023 | Bd Onclarity |
| Gilead Sciences, INC. | $16.05 | 2019 | |
| Roche Diagnostics Corporation | $14.37 | 2019 | |
| Tris Pharma INC | $14.12 | 2019 | |
| Allergan, INC. | $12.91 | 2019 | |
| Shield Therapeutics INC | $12.91 | 2023 | Accrufer |
| Mayne Pharma Commercial LLC | $6.79 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hutchison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.